KRAS G12V

Katharine M Wright1,2,3,4, Sarah R DiNapoli2,5,6, Michelle S Miller1,2,3,7

  • 1Department of Biophysics and Biophysical Chemistry, The Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.

Nature communications
|August 21, 2023
PubMed
概括

这项研究揭示了抗体如何能够向癌症特异性突变相关新抗原 (MANAs). 结构分析确定了疏水性相互作用是区分突变KRAS与正常的关键,用于癌症治疗.